Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IMAB027 (ASP1650) is a specific monoclonal antibody targeting CLDN6 (Claudin 6), a membrane protein of tight junctions aberrantly overexpressed in multiple human cancers, notably in ovarian cancers. This compound exhibits anti-tumor properties and induces apoptosis specifically in CLDN6-positive ovarian and testicular cancer cell lines [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | IMAB027 (ASP1650) is a specific monoclonal antibody targeting CLDN6 (Claudin 6), a membrane protein of tight junctions aberrantly overexpressed in multiple human cancers, notably in ovarian cancers. This compound exhibits anti-tumor properties and induces apoptosis specifically in CLDN6-positive ovarian and testicular cancer cell lines [1]. |
In vitro | IMAB027 selectively binds to CLDN6 rather than closely related family members such as Claudins 3, 4, and 9 [1]. In ovarian and testicular cancer cell lines expressing CLDN6+, IMAB027 induces selective antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) in target cells [1]. |
In vivo | IMAB027 can reduce tumor growth and enhance overall survival rates in mice transplanted with human CLDN6+ cells [1]. |
Synonyms | ASP1650 |
Molecular Weight | N/A |
CAS No. | 1650599-68-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IMAB027 1650599-68-0 ASP-1650 ASP 1650 ASP1650 IMAB-027 IMAB 027 inhibitor inhibit